Zenas BioPharma (ZBIO) Cash & Current Investments (2023 - 2026)
Zenas BioPharma (ZBIO) posted Cash & Current Investments of $673.9 million for Q2 2026, up 145.1% from $274.9 million a year earlier but down 6.2% from the prior quarter.
Zenas BioPharma (ZBIO) Cash & Current Investments (2023 - 2026) Analysis & Trends
At the end of FY2025, Zenas BioPharma's Cash & Current Investments came in at $360.5 million, up 2.8% from FY2024.
- In prior years, Zenas BioPharma's Cash & Current Investments was $350.8 million in FY2024 (+517.0%) and $56.86 million in FY2023.
- Quarterly Cash & Current Investments has run from a low of $37.15 million in Q1 2024 to a high of $718.5 million in Q1 2026 over five years.
- On a year-over-year basis, Cash & Current Investments has increased in each of the last three quarters, with growth averaging 250.2% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q1 2025, with growth of 745.7%; the weakest was Q3 2025, with a decline of 22.0%.
- According to Business Quant data, Cash & Current Investments for the three prior quarters was $718.5 million (Q1 2026), $360.5 million (Q4 2025) and $301.6 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 17.23 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 7.14 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 7.69 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 11.70 Bn |
| 10 | Zenas BioPharma | 1.70 Bn | 1.03 Bn | - | 673.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 673.90 Mn |
| Mar 31, 2026 | 718.50 Mn |
| Dec 31, 2025 | 360.50 Mn |
| Sep 30, 2025 | 301.60 Mn |
| Jun 30, 2025 | 274.90 Mn |
| Mar 31, 2025 | 314.20 Mn |
| Dec 31, 2024 | 350.80 Mn |
| Sep 30, 2024 | 386.80 Mn |
| Jun 30, 2024 | 183.93 Mn |
| Mar 31, 2024 | 37.15 Mn |
| Dec 31, 2023 | 56.86 Mn |
| Sep 30, 2023 | 72.31 Mn |
Zenas BioPharma Cash & Current Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ZBIO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-current-investments", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();